Silihan lan utang jangka dawa perusahaan Tactile Systems Technology (TCMD)

Tactile Systems Technology (TCMD) minimizes clinical risks by offering home lymphedema therapy systems covered by US insurance. The company is actively expanding its range of available devices, which serve as substitutes for costly inpatient visits. This daily price chart on GURU.Markets, where the indicator stands at 0.01, reflects the dominance of US sales, which shields the business from geopolitical conflicts despite a potential rise in the cost of imported electronics.

This metric is based on reporting data, aggregating all liabilities with a maturity of more than one year. It measures the long-term credit load, allowing for an assessment of financial stability and default risk. For Tactile Systems Technology (TCMD), such loans may fund the scaling of production for lymphedema therapy devices amid stable demand. By analyzing the value of the corporation's long-term loans and borrowings, an investor determines the balance between debt capital and the lifetime stream of service revenues.